ETHICON INC. SURGICEL ABSORBABLE HEMOSTAT UNKNOWN; AGENT, ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED
|
Back to Search Results |
|
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Inflammation (1932); Paresis (1998); Foreign Body In Patient (2687); Convulsion/Seizure (4406)
|
Event Date 02/21/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Product complaint # (b)(4).H6.Component code: g07002 - device not returned.This report is related to a journal article, therefore no product will be returned for analysis and the manufacturing record evaluation cannot be reviewed as the lot number has not been provided.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number(s).Does the surgeon believe that ethicon products involved caused and/or contributed to the post-operative patient consequences described in the article? does the surgeon believe there was any deficiency with the ethicon products used in this procedure? was there any medical or surgical intervention performed (product removed; re-operation; re-closure; prescription steroids; antibiotics prescribed)? if so, please clarify.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.Can specific patient demographics: initials; age or date of birth; bmi; gender; patient pre-existing medical conditions (i.E.Allergies, history of reactions), all concomitant medications, past medical history, any treatment required for events, dose, frequency, and therapy dates of study drugs be provided? citation: j neurosurg case lessons 2022;3(8): case21479.Doi: 10.3171/case21479.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
Event Description
|
It was reported via a journal article: title: intracranial gossypiboma 9 years after intracranial pressure bolt insertion: illustrative case.Authors: ryan t.S.Loh, mbbchir,1 tomasz matys, md, phd, frcr,2 kieren s.J.Allinson, mbchb, frcpath, efn,3 and thomas santarius, md, phd, frcs(sn)4.Citation: j neurosurg case lessons 2022;3(8): case21479.Doi: 10.3171/case21479.The authors report a case of an intracranial gossypiboma, which is exceedingly rare and frequently radiologically indistinguishable from other lesions.A 35-year-old woman, who sustained a severe traumatic brain injury in a road traffic accident, underwent insertion of a triple-bolt monitoring device consisting of a licox brain tissue oxygenation probe (integra lifesciences), microdialysis catheter, and codman intraparenchymal icp probe (integra lifesciences), which is performed routinely in the authors' unit.Small superficial bleeding from the dura and brain surface during insertion was controlled with surgicel (ethicon).She did not undergo any other surgical interventions and subsequently made a full recovery.Reported complications include gossypiboma (n=1).In conclusion, the authors show that gossypibomas can occur following a relatively minor procedure and remain clinically and radiologically silent for much longer than previously reported.
|
|
Search Alerts/Recalls
|
|
|